Overnight Ebola news on Ebola was not too bad. A suspected case has appeared in Berlin but is low probability:
A female patient in Berlin is currently awaiting tests to determine whether she has Ebola, but spokespeople from the Charité hospital where she is being treated say it is unlikely she has the virus.
“The patient suspected of having Ebola has arrived at the Charité. The Charité experts do not assume at this time that they are dealing with a case of Ebola. The patient has not stayed in one of the affected regions. The physicians are leaning more toward an infectious gastrointestinal disease. Of course, in order to formally rule out Ebola, a blood analysis will be carried out,” Manuela Zingl, a spokeswoman for the Berlin Charité hospital where the patient is being treated, said in a statement sent to TIME.
Another suspected case in Spain has tested negative. In Africa, Liberia has rounded up the various patients dispersed by the recent lunatic ransacking of a border clinic:
“We are glad to confirm that all of the 17 individuals have been accounted for and have now been transferred to JFK Ebola specialist treatment centre,” said Lewis Brown.
He also said three infected African doctors who had received the experimental Ebola drug ZMapp were showing “remarkable signs of improvement”, quoting an assessment by the doctor overseeing their treatment.
The second American that has been treated with ZMapp is also recovering:
The husband of an American missionary under treatment for Ebola at Emory University Hospital said Monday his wife is gaining strength, while three ill Liberian doctors who were given an experimental drug also showed signs of improvement.
Four Ebola patients in Nigeria were also recovering.
American missionary David Writebol said that he had been released on Sunday from quarantine in Charlotte, North Carolina, and traveled the same day to Atlanta to visit his wife, Nancy Writebol, who is in a special isolation unit at Emory.
Meanwhile the latest statistics show no slowing in the West African outbreak:
David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific’s leading geo-politics and economics portal.
He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.
